Michael Voronkov

1.5k total citations
51 papers, 1.1k citations indexed

About

Michael Voronkov is a scholar working on Organic Chemistry, Molecular Biology and Physiology. According to data from OpenAlex, Michael Voronkov has authored 51 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Organic Chemistry, 12 papers in Molecular Biology and 10 papers in Physiology. Recurrent topics in Michael Voronkov's work include Parkinson's Disease Mechanisms and Treatments (6 papers), Skin Protection and Aging (6 papers) and Multicomponent Synthesis of Heterocycles (6 papers). Michael Voronkov is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (6 papers), Skin Protection and Aging (6 papers) and Multicomponent Synthesis of Heterocycles (6 papers). Michael Voronkov collaborates with scholars based in United States, Russia and New Zealand. Michael Voronkov's co-authors include Jeffry B. Stock, Alan R. Katritzky, Steven P. Braithwaite, M. Maral Mouradian, Mingyi Wang, Peter J. Steel, Suoming Zhang, José R. Fernández, Tian‐Bao Huang and Eunsung Junn and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Neuroscience and PLoS ONE.

In The Last Decade

Michael Voronkov

49 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael Voronkov United States 17 363 317 241 199 177 51 1.1k
Andrea Mattarei Italy 25 164 0.5× 896 2.8× 90 0.4× 167 0.8× 199 1.1× 88 1.6k
Soosung Kang South Korea 21 374 1.0× 704 2.2× 81 0.3× 232 1.2× 259 1.5× 54 1.4k
Artur Wnorowski Poland 19 150 0.4× 341 1.1× 40 0.2× 109 0.5× 77 0.4× 59 1.0k
Hiroyuki Masayasu Japan 13 207 0.6× 439 1.4× 46 0.2× 139 0.7× 80 0.5× 22 1.2k
Maria Anna Rosei Italy 18 103 0.3× 277 0.9× 72 0.3× 108 0.5× 145 0.8× 40 804
Gyan Modi India 21 202 0.6× 472 1.5× 91 0.4× 283 1.4× 139 0.8× 47 1.2k
Rita Turnaturi Italy 22 131 0.4× 663 2.1× 34 0.1× 208 1.0× 403 2.3× 55 1.1k
Carl B. Goodman United States 17 126 0.3× 399 1.3× 61 0.3× 87 0.4× 274 1.5× 39 959
Harald O. Borbe Germany 17 167 0.5× 435 1.4× 143 0.6× 49 0.2× 272 1.5× 34 917
Caterina Vicidomini Italy 20 144 0.4× 445 1.4× 395 1.6× 96 0.5× 188 1.1× 46 1.3k

Countries citing papers authored by Michael Voronkov

Since Specialization
Citations

This map shows the geographic impact of Michael Voronkov's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Voronkov with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Voronkov more than expected).

Fields of papers citing papers by Michael Voronkov

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael Voronkov. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Voronkov. The network helps show where Michael Voronkov may publish in the future.

Co-authorship network of co-authors of Michael Voronkov

This figure shows the co-authorship network connecting the top 25 collaborators of Michael Voronkov. A scholar is included among the top collaborators of Michael Voronkov based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael Voronkov. Michael Voronkov is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kikuchi, Yuki, Eriko Sugano, Yuka Endo, et al.. (2022). SIG-1451, a Novel, Non-Steroidal Anti-Inflammatory Compound, Attenuates Light-Induced Photoreceptor Degeneration by Affecting the Inflammatory Process. International Journal of Molecular Sciences. 23(15). 8802–8802. 2 indexed citations
2.
Волков, В. А., et al.. (2021). Mechanism of the Antioxidant Activity and Structure–Activity Relationship of N-Monosubstituted Amino Acid Derivatives of Fullerene С60. Kinetics and Catalysis. 62(3). 395–403. 4 indexed citations
3.
Voronkov, Michael, et al.. (2021). Modifying naloxone to reverse fentanyl-induced overdose. International Journal of Pharmaceutics. 611. 121326–121326. 8 indexed citations
4.
Voronkov, Michael, et al.. (2021). A vicious cycle of neuropathological, cognitive and behavioural sequelae of repeated opioid overdose. International Journal of Drug Policy. 97. 103362–103362. 7 indexed citations
5.
Волков, В. А., et al.. (2021). Aqueous Propylene Glycol Extracts from Medicinal Plants: Chemical Composition, Antioxidant Activity, Standardization, and Extraction Kinetics. Inorganic Materials. 57(14). 1404–1412. 6 indexed citations
6.
Voronkov, Michael, et al.. (2021). NB-33, a bioreversible opioid derivative of Nalbuphine, shows enhanced pharmacodynamics. European Journal of Pharmaceutical Sciences. 159. 105734–105734. 2 indexed citations
7.
8.
Voronkov, Michael, et al.. (2020). Does a hypoxic injury from a non-fatal overdose lead to an Alzheimer Disease?. Neurochemistry International. 143. 104936–104936. 5 indexed citations
9.
Zhang, Jie, Hye-Jin Park, Eun Su Park, et al.. (2018). Synergistic neuroprotection by coffee components eicosanoyl-5-hydroxytryptamide and caffeine in models of Parkinson's disease and DLB. Proceedings of the National Academy of Sciences. 115(51). E12053–E12062. 65 indexed citations
10.
Staniszewski, Agnieszka, Hong Zhang, Scott L. Melideo, et al.. (2017). Eicosanoyl-5-hydroxytryptamide (EHT) prevents Alzheimer’s disease-related cognitive and electrophysiological impairments in mice exposed to elevated concentrations of oligomeric beta-amyloid. PLoS ONE. 12(12). e0189413–e0189413. 22 indexed citations
11.
Fernández, José R., et al.. (2017). 440 SIG-1459 and SIG-1460: Novel anti-acne isoprenylcysteine compounds. Journal of Investigative Dermatology. 137(10). S267–S267. 1 indexed citations
12.
Fernández, José R., et al.. (2016). In vitro and clinical evaluation of SIG1273: a cosmetic functional ingredient with a broad spectrum of anti‐aging and antioxidant activities. Journal of Cosmetic Dermatology. 15(2). 150–157. 4 indexed citations
13.
Fernández, José R., et al.. (2016). N-Acetylglutaminoyl-S-farnesyl-l-cysteine (SIG-1191): an anti-inflammatory molecule that increases the expression of the aquaglyceroporin, aquaporin-3, in human keratinocytes. Archives of Dermatological Research. 309(2). 103–110. 6 indexed citations
14.
Park, Eun Su, Jong‐Min Woo, Bhagya Laxmi Dyavar Shetty, et al.. (2015). Dual κ‐agonist/μ‐antagonist opioid receptor modulation reduces levodopa‐induced dyskinesia and corrects dysregulated striatal changes in the nonhuman primate model ofParkinson disease. Annals of Neurology. 77(6). 930–941. 42 indexed citations
15.
Basurto‐Islas, Gustavo, Julie Blanchard, Yunn Chyn Tung, et al.. (2014). Therapeutic benefits of a component of coffee in a rat model of Alzheimer's disease. Neurobiology of Aging. 35(12). 2701–2712. 49 indexed citations
16.
Lee, Kang‐Woo, Joo‐Young Im, Jongmin Jacob Woo, et al.. (2013). Neuroprotective and Anti-inflammatory Properties of a Coffee Component in the MPTP Model of Parkinson's Disease. Neurotherapeutics. 10(1). 143–153. 59 indexed citations
17.
Braithwaite, Steven P., Michael Voronkov, Jeffry B. Stock, & M. Maral Mouradian. (2012). Targeting phosphatases as the next generation of disease modifying therapeutics for Parkinson’s disease. Neurochemistry International. 61(6). 899–906. 24 indexed citations
18.
Lee, Kang-Woo, Walter W. Chen, Eunsung Junn, et al.. (2011). Enhanced Phosphatase Activity Attenuates α-Synucleinopathy in a Mouse Model. Journal of Neuroscience. 31(19). 6963–6971. 148 indexed citations
19.
Katritzky, Alan R., Michael Voronkov, Alfredo Pastor, & Douglas B. Tatham. (1999). Direct Synthesis of a-(Benzotriazol-1-yl)alkyl Ethers. Heterocycles. 51(8). 1877–1877. 7 indexed citations
20.
Xie, Hong, Michael Voronkov, Dennis C. Liotta, et al.. (1995). Phosphatidyl-2′,3′-dideoxy-3′-thiacytidine: synthesis and antiviral activity in hepatitis B- and HIV-1-infected cells. Antiviral Research. 28(2). 113–120. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Andrea Mattarei Breakdown of academic impact, for papers by Soosung Kang Breakdown of academic impact, for papers by Artur Wnorowski Breakdown of academic impact, for papers by Hiroyuki Masayasu Breakdown of academic impact, for papers by Maria Anna Rosei Breakdown of academic impact, for papers by Gyan Modi Breakdown of academic impact, for papers by Rita Turnaturi Breakdown of academic impact, for papers by Carl B. Goodman Breakdown of academic impact, for papers by Harald O. Borbe Breakdown of academic impact, for papers by Caterina Vicidomini
Rankless by CCL
2026